Literature DB >> 7693576

Heterogeneity of DNA and RNA in Hunter patients.

T Annella1, A Daniele, P Di Natale.   

Abstract

Genomic DNA and total RNA from lymphoblasts of nine unrelated Italian patients affected with Hunter syndrome were analyzed using a human cDNA clone coding for the lysosomal enzyme iduronate-2-sulphatase (IDS). Southern blot analysis resulted in patterns similar to the normal control for seven of the patients analyzed; an aberrant pattern was observed in two patients (F.N. and P.D.), suggesting deletions/rearrangement in the IDS gene. Northern blot analysis showed in seven patients, a pattern similar to the normal control; for patients F.N. and P.D. the pattern was atypical, i.e., normal RNA species were absent whereas two different transcripts occurred. These data confirm the heterogeneity of the molecular defects causing Hunter disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693576     DOI: 10.1007/bf01247333

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Genetic mapping on the mouse X chromosome of human cDNA clones for the fragile X and Hunter syndromes.

Authors:  C J Faust; A J Verkerk; P J Wilson; C P Morris; J J Hopwood; B A Oostra; G E Herman
Journal:  Genomics       Date:  1992-04       Impact factor: 5.736

2.  Biochemical diagnosis of Hunter syndrome on Epstein-Barr virus-transformed lymphoblastoid cell lines.

Authors:  E Morabito; I Giambarrasi; M Rocchi; P Di Natale
Journal:  Clin Chim Acta       Date:  1989-05-15       Impact factor: 3.786

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Iduronate sulfatase from human placenta.

Authors:  P Di Natale; A Daniele
Journal:  Biochim Biophys Acta       Date:  1985-05-08

5.  Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Authors:  J Bielicki; C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

6.  Biochemical diagnosis of mucopolysaccharidoses: experience of 297 diagnoses in a 15-year period (1977-1991).

Authors:  P Di Natale; T Annella; A Daniele; T De Luca; E Morabito; R Pallini; P Rosario; G Spagnuolo
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.

Authors:  G Palmieri; V Capra; G Romano; M D'Urso; S Johnson; D Schlessinger; P Morris; J Hopwood; P Di Natale; R Gatti; A Ballabio
Journal:  Genomics       Date:  1992-01       Impact factor: 5.736

9.  Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.

Authors:  M L Steén-Bondeson; N Dahl; T Tönnesen; W J Kleijer; G Seidlitz; K H Gustavson; P J Wilson; C P Morris; J J Hopwood; U Pettersson
Journal:  Hum Mol Genet       Date:  1992-06       Impact factor: 6.150

10.  Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme.

Authors:  J Bielicki; J J Hopwood; P J Wilson; D S Anson
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

View more
  2 in total

1.  Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.

Authors:  T C Olsen; H G Eiken; P M Knappskog; B F Kase; J E Månsson; H Boman; J Apold
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

2.  Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.

Authors:  J J Jonsson; E L Aronovich; S E Braun; C B Whitley
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.